SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-008888
Filing Date
2024-02-01
Accepted
2024-02-01 13:15:35
Documents
16
Period of Report
2024-02-01
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea192611-8k_silopharma.htm   iXBRL 8-K 26292
2 PRESS RELEASE DATED FEBRUARY 1, 2024 ea192611ex99-1_silopharm.htm EX-99.1 10600
3 GRAPHIC ex99-1_001.jpg GRAPHIC 10609
  Complete submission text file 0001213900-24-008888.txt   226922

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE silo-20240201.xsd EX-101.SCH 3021
5 XBRL LABEL FILE silo-20240201_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE silo-20240201_pre.xml EX-101.PRE 22363
17 EXTRACTED XBRL INSTANCE DOCUMENT ea192611-8k_silopharma_htm.xml XML 3500
Mailing Address 677 N. WASHINGTON BLVD SARASOTA FL 34236
Business Address 677 N. WASHINGTON BLVD SARASOTA FL 34236 (718) 400-9031
Silo Pharma, Inc. (Filer) CIK: 0001514183 (see all company filings)

IRS No.: 462137136 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41512 | Film No.: 24585970
SIC: 2300 Apparel & Other Finishd Prods of Fabrics & Similar Matl
(CF Office: 04 Manufacturing)